Valuations in pharma and biotech are driven by assumptions that vary based on the unique risk profile of the company or product.
CELforPharma faculty member Dr Patrik Frei, from Pharma-Biotech Product & Company Valuation, has made a handy checklist that helps you identify critical factors and provides a framework for assessing aspects that could influence the valuation.
The checklist focuses on three essential areas that determine the value of a life sciences company or product. Each factor is scored on a scale from 1 (none/very poor) to 6 (high) – giving you a quick visual read on whether a company or product sits at the strong or weak end of the spectrum.
Want to take this guide with you?
Download the full checklist below 👇
1. Management
A company's leadership plays a pivotal role in its success. Assessing the quality of management involves evaluating:
Skills Completeness: Are the right competencies in place for effective decision-making?
Track Record: Does the management team have a history of delivering results?
Motivation and Incentives: Are incentives aligned with long-term value creation?
Emotional Intelligence and Social Competence: Can leaders inspire confidence among stakeholders?
2. Market environment
Understanding the market environment is crucial for identifying growth opportunities and anticipating challenges. The checklist includes:
Market Potential: What is the current and future demand for the product or service?
Competitive Landscape: Who are the key competitors, and what strategies are they employing?
Regulatory Dependencies: Are there political or legal factors that could impact valuation?
Industry Structure: How do competitors, supplier and customer dependencies shape the company’s position?
3. Science & technology
In a sector driven by innovation, the strength of a company’s science and technology underpins its value. Key factors include:
Intellectual Property (IP): Is the IP portfolio robust and defensible?
Unique Selling Proposition: What differentiates the product in the market?
Alliances and Partnerships: Are collaborations helping accelerate development?
Time to Market: Can the company bring products to market efficiently?
Download the full checklist for the complete 1-6 rating scale:
Continue your learning from Patrik
If you’d like to learn more from Patrik, CELforPharma also offers a 1-day, hands-on course where you'll learn how to:
- Understand the key valuation methods used for life-science companies and pharmaceutical products
- Gain insight into how risk profiles are assessed and optimised before valuation
- Calculate company value using DCF/rNPV, comparables, and the Venture Capital method
- Apply risk-adjusted Net Present Value (rNPV) to evaluate compounds in development
Pharma-Biotech Product & Company Valuation
With Dr Patrik Frei
Don’t miss the latest insights from our expert faculty
Subscribe to our newsletter to:
- Stay on top of the latest expert insights
- Receive invitations to upcoming educational webinars
- Get updates on our courses and training programmes